---
title: "Cboe Backs Lawsuit Challenging CFTC Approval of Stock Perpetual Derivatives"
description: "Cboe joins Citadel Securities and the Healthy Markets Association to seek injunctive relief against CFTC-authorized single-stock perpetuals."
url: https://basisdesk.news/news/cboe-joins-lawsuit-challenging-cftc-stock-perpetuals
published: 2026-11-03T17:46:39.333Z
modified: 2026-11-03T17:46:39.333Z
section: Regulation & Policy
author: Basis Desk Newsroom (AI-generated, source-verified)
sentiment: neutral
tickers: []
tags: [cftc, cboe, citadel-securities, derivatives, perpetual-futures, litigation]
license: Quote with attribution to Basis Desk (basisdesk.news). Not financial advice.
---

# Cboe Backs Lawsuit Challenging CFTC Approval of Stock Perpetual Derivatives

Cboe joins Citadel Securities and the Healthy Markets Association to seek injunctive relief against CFTC-authorized single-stock perpetuals.

## At a glance

- **What happened:** Cboe joined a Capital Markets Alliance lawsuit against the CFTC on Nov. 3, 2026, seeking an injunction against single-stock perpetual derivatives.
- **Why it matters:** The lawsuit challenges the CFTC's jurisdiction to authorize perpetual instruments tied to U.S. equities outside securities regulations.
- **Who is affected:** The CFTC, Cboe, Citadel Securities, and market participants operating or trading equity-linked derivatives.
- **What's next:** A court review of the alliance's request for injunctive relief against the CFTC authorizations.
- **Status:** court-ruling
- **Primary source:** [Cboe Joins Capital Markets Alliance Challenge to CFTC Approval of Single-Stock Perpetual Derivatives](https://www.prnewswire.com/news-releases/cboe-joins-capital-markets-alliance-challenge-to-cftc-approval-of-single-stock-perpetual-derivatives-302928156.html) — PR Newswire

## Key points

- Cboe joined the Capital Markets Alliance lawsuit challenging CFTC approvals of single-stock and ETF perpetual derivatives [1].
- The coalition, including Citadel Securities and Healthy Markets Association, is seeking injunctive relief against the CFTC [1].
- Cboe argued the approvals circumvent U.S. securities laws and create regulatory arbitrage across derivatives venues [1].

## Editorial remark

- **Context:** The CFTC has expanded derivatives oversight to new structures, drawing scrutiny from traditional exchanges and market makers over agency boundaries.
- **Impact:** U.S. derivatives exchanges, market makers, and retail brokerages face potential jurisdictional shifts depending on whether the court grants an injunction.
- **Watch:** The court's initial scheduling order and any decision on the Capital Markets Alliance's motion for preliminary injunctive relief.

Cboe Global Markets announced on Nov. 3, 2026, that it has joined a legal action initiated by the Capital Markets Alliance challenging the Commodity Futures Trading Commission's approval of perpetual derivatives based on U.S. equities and exchange-traded funds [1]. The alliance includes market participants such as Cboe, Citadel Securities, and the Healthy Markets Association [1].

The litigation requests injunctive relief to halt the offering of single-stock perpetual instruments on CFTC-supervised venues [1]. Cboe Chief Executive Officer Craig Donohue stated that the agency's approvals bypass investor protection standards established under federal securities laws for more than nine decades [1]. Donohue stated that products linked to single issuers, equity indices, or corporate outcomes belong exclusively on securities platforms regulated under statutory securities frameworks, rather than commodities venues [1].

## Allegations of Regulatory Arbitrage

Cboe contended that the CFTC permitted multiple securities-related derivatives without publishing a clear legal foundation, running contrary to historical precedent and earlier agency decisions [1]. The exchange operator rejected assertions that its objections are commercially driven, noting that it already owns and operates CFTC-regulated trading and clearing facilities where it could list comparable products if permitted [1].

Instead, the coalition asserted that listing equity contracts on commodities venues fosters regulatory arbitrage and avoids federal and state investor safeguards [1]. Cboe noted that earlier attempts to resolve these jurisdiction issues through regulatory forums, public comment periods, and direct discussions with lawmakers had failed to alter the agency's stance [1].

## Sources

1. [Cboe Joins Capital Markets Alliance Challenge to CFTC Approval of Single-Stock Perpetual Derivatives](https://www.prnewswire.com/news-releases/cboe-joins-capital-markets-alliance-challenge-to-cftc-approval-of-single-stock-perpetual-derivatives-302928156.html) — PR Newswire, 2026-11-03

---
Basis Desk Newsroom · AI-generated, source-verified · https://basisdesk.news/about/how-we-use-ai